心脏节律紊乱管理术后死亡与脑血管事件分析
导线拔除术死亡率最高(1.9%),心脏压塞是最常见的直接死因。
要点
- 导线拔除术死亡率和脑血管事件率最高,需重点防范。
- 与操作直接相关的死亡中48%发生于器械植入术。
- 心脏压塞是最常见直接死因,即使低风险操作也需快速识别处理。
核心结论
- 心脏节律紊乱管理操作总体死亡率0.36%、脑血管事件率0.12%,导线拔除术风险最高。
- 与操作直接相关的死亡中近半数发生于器械植入术,心脏压塞为最常见直接死因。
主要发现
- 总体死亡率为0.36%(95%CI 0.31-0.42),脑血管事件率为0.12%(95%CI 0.09-0.16)。
- 导线拔除术总体死亡率1.9%(95%CI 1.34-2.61)、脑血管事件率0.62%(95%CI 0.32-1.07),均为最高。
- 与操作直接相关的死亡中48%发生于器械植入术患者。
- 心脏压塞是最常见直接死因(40%),感染是最常见间接死因(29%)。
- 总体30天死亡率为0.76%,导线拔除术最高(3.08%),其次为器械植入术(0.94%)。
临床怎么用
- 应建立快速识别和处理心脏压塞的流程,即使对器械植入等通常认为低风险的操作也应如此。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recognition of rates and causes of hard, patient-centered outcomes of death and cerebrovascular events (CVEs) after heart rhythm disorder management (HRDM) procedures is an essential step for the development of quality improvement programs in electrophysiology laboratories. Our primary aim was to assess and characterize death and CVEs (stroke or transient ischemic attack) after HRDM procedures over a 17-year period. METHODS: We performed a retrospective cohort study of all patients undergoing HRDM procedures between January 2000 and November 2016 at the Mayo Clinic. Patients from all 3 tertiary academic centers (Rochester, Phoenix, and Jacksonville) were included in the study. All in-hospital deaths and CVEs after HRDM procedures were identified and were further characterized as directly or indirectly related to the HRDM procedure. Subgroup analysis of death and CVE rates was performed for ablation, device implantation, electrophysiology study, lead extraction, and defibrillation threshold testing procedures. RESULTS: A total of 48 913 patients (age, 65.7±6.6 years; 64% male) who underwent a total of 62 065 HRDM procedures were included in the study. The overall mortality and CVE rates in the cohort were 0.36% (95% confidence interval [CI], 0.31-0.42) and 0.12% (95% CI, 0.09-0.16), respectively. Patients undergoing lead extraction had the highest overall mortality rate at 1.9% (95% CI, 1.34-2.61) and CVE rate at 0.62% (95% CI, 0.32-1.07). Among patients undergoing HRDM procedures, 48% of deaths directly related to the HDRM procedure were among patients undergoing device implantation procedures. Overall, cardiac tamponade was the most frequent direct cause of death (40%), and infection was the most common indirect cause of death (29%). The overall 30-day mortality rate was 0.76%, with the highest being in lead extraction procedures (3.08%), followed by device implantation procedures (0.94%). CONCLUSIONS: Half of the deaths directly related to an HRDM procedure were among the patients undergoing device implantation procedures, with cardiac tamponade being the most common cause of death. This highlights the importance of the development of protocols for the quick identification and management of cardiac tamponade even in procedures typically believed to be lower risk such as device implantation.
引用
- Lee JZ, Ling J, Diehl NN, et al. Mortality and Cerebrovascular Events After Heart Rhythm Disorder Management Procedures. Circulation. 2017. PMID: 29046320. doi:10.1161/CIRCULATIONAHA.117.030523
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。